An Act To Expand Access And Reduce Barriers To Access To Naloxone Hydrochloride And Other Opioid Overdose-Reversing Medications
LD 710 expands access to naloxone and similar opioid overdose-reversing medications in Maine. It removes training requirements for community overdose prevention programs and recovery residences that distribute these medications, and allows municipalities to place naloxone in public locations like wall-mounted boxes or vending machines in places such as libraries or parks. The bill also provides immunity from legal liability for anyone who administers these medications in good faith during an opioid overdose emergency. These changes apply to both naloxone hydrochloride and other approved opioid overdose-reversing medications.
Bill status
signed
all 5 stages cleared
Introduction
Feb 2025
Committee Review
May 2025
House Passage
May 2025
Senate Passage
May 2025
Signed into Law
May 2025
Introduced Feb 20, 2025
Signed May 29, 2025
Floor votes
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
19
Key actions
5
Committee
3
May 29, 2025
Signed into law
Signed by Governor
executive
May 27, 2025
Upper · Passed
PASSED TO BE ENACTED, in concurrence.
upper
May 27, 2025
Lower · Passed
PASSED TO BE ENACTED.
lower
May 22, 2025
Upper · Passed
Committee Amendment "A" (H-207) READ and ADOPTED, in concurrence.
upper
May 19, 2025
Legislature · Passed
Reported Out - OTP-AM
legislature
Feb 20, 2025
Committee
The Bill was REFERRED to the Committee on HEALTH AND HUMAN SERVICES pursuant to Joint Rule 308.2 and ordered printed pursuant to Joint Rule 401.
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Sam Zager
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about LD 710
Scope: ME
Hi! I can help you understand LD 710. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline